Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Gynecol Oncol. 2019 Nov 24;156(1):62–69. doi: 10.1016/j.ygyno.2019.11.002

Figure 2.

Figure 2.

Comparison of (A) overall survival and (B) recurrence-free survival, adjusted using inverse-probability of treatment weighting, between node-negative patients in the sentinel lymph node (SLN) cohort (n=92) and the lymphadenectomy (LND) cohort (n=76).